Which has higher valuation & earnings, CLPT or HSDT?

ClearPoint Neuro has higher revenue and earnings than Solana. ClearPoint Neuro is trading at a lower price-to-earnings ratio than Solana, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio ClearPoint Neuro $36.97M 10.90 -$25.54M -$1.01 N/A Solana $6.02M 14.94 -$40.89M -$109.67 N/A

Is CLPT or HSDT more profitable?

ClearPoint Neuro has a net margin of -71.57% compared to Solana's net margin of -1,427.15%. Solana's return on equity of -67.57% beat ClearPoint Neuro's return on equity. Company Net Margins Return on Equity Return on Assets ClearPoint Neuro -71.57% -140.96% -36.98% Solana -1,427.15% -67.57% -24.09%

Which has preferable earnings and valuation, DCTH or HSDT?

Delcath Systems has higher revenue and earnings than Solana. Solana is trading at a lower price-to-earnings ratio than Delcath Systems, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Delcath Systems $85.23M 4.75 $2.70M $0.01 1,172.00 Solana $6.02M 14.94 -$40.89M -$109.67 N/A

Is DCTH or HSDT more profitable?

Delcath Systems has a net margin of 0.62% compared to Solana's net margin of -1,427.15%. Delcath Systems' return on equity of 0.51% beat Solana's return on equity. Company Net Margins Return on Equity Return on Assets Delcath Systems 0.62% 0.51% 0.46% Solana -1,427.15% -67.57% -24.09%

Do analysts recommend CNXU or HSDT?

Solana has a consensus target price of $3.50, suggesting a potential upside of 127.27%. Given Solana's stronger consensus rating and higher possible upside, analysts clearly believe Solana is more favorable than Conexeu Sciences. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Conexeu Sciences 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Solana 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 2.50

Which has stronger valuation and earnings, CNXU or HSDT?

Conexeu Sciences has higher earnings, but lower revenue than Solana. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Conexeu Sciences N/A N/A N/A N/A N/A Solana $6.02M 14.94 -$40.89M -$109.67 N/A

Which has higher valuation and earnings, HSDT or CV?

CapsoVision has higher revenue and earnings than Solana. CapsoVision is trading at a lower price-to-earnings ratio than Solana, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Solana $6.02M 14.94 -$40.89M -$109.67 N/A CapsoVision $13.55M 26.51 -$25.32M -$2.34 N/A

Is HSDT or CV more profitable?

CapsoVision has a net margin of -198.87% compared to Solana's net margin of -1,427.15%. CapsoVision's return on equity of 0.00% beat Solana's return on equity. Company Net Margins Return on Equity Return on Assets Solana -1,427.15% -67.57% -24.09% CapsoVision -198.87% N/A -136.03%

Which has stronger valuation & earnings, CARL or HSDT?

Carlsmed has higher revenue and earnings than Solana. Carlsmed is trading at a lower price-to-earnings ratio than Solana, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Carlsmed $50.51M 6.15 -$29.63M -$2.51 N/A Solana $6.02M 14.94 -$40.89M -$109.67 N/A

Is CARL or HSDT more profitable?

Carlsmed has a net margin of -57.76% compared to Solana's net margin of -1,427.15%. Carlsmed's return on equity of -60.74% beat Solana's return on equity. Company Net Margins Return on Equity Return on Assets Carlsmed -57.76% -60.74% -29.84% Solana -1,427.15% -67.57% -24.09%

Solana (HSDT) Competitors

$1.54 +0.03 (+1.99%)

Closing price 04:00 PM Eastern

Extended Trading

$1.54 +0.00 (+0.26%)

As of 07:31 PM Eastern

Compare

HSDT vs. CLPT, DCTH, CNXU, CV, and CARL

Should you buy Solana stock or one of its competitors? MarketBeat compares Solana with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Solana include ClearPoint Neuro (CLPT), Delcath Systems (DCTH), Conexeu Sciences (CNXU), CapsoVision (CV), and Carlsmed (CARL). These companies are all part of the "medical equipment" industry.

How does Solana compare to ClearPoint Neuro?

ClearPoint Neuro (NASDAQ:CLPT) and Solana (NASDAQ:HSDT) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, profitability, valuation, institutional ownership, earnings, dividends, risk and media sentiment.

ClearPoint Neuro has higher revenue and earnings than Solana. ClearPoint Neuro is trading at a lower price-to-earnings ratio than Solana, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ClearPoint Neuro	$36.97M	10.90	-$25.54M	-$1.01	N/A
Solana	$6.02M	14.94	-$40.89M	-$109.67	N/A

30.1% of ClearPoint Neuro shares are held by institutional investors. Comparatively, 18.6% of Solana shares are held by institutional investors. 6.9% of ClearPoint Neuro shares are held by company insiders. Comparatively, 14.4% of Solana shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

ClearPoint Neuro has a net margin of -71.57% compared to Solana's net margin of -1,427.15%. Solana's return on equity of -67.57% beat ClearPoint Neuro's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
ClearPoint Neuro	-71.57%	-140.96%	-36.98%
Solana	-1,427.15%	-67.57%	-24.09%

In the previous week, ClearPoint Neuro and ClearPoint Neuro both had 1 articles in the media. ClearPoint Neuro's average media sentiment score of 1.87 equaled Solana'saverage media sentiment score.

Company	Overall Sentiment
ClearPoint Neuro	Very Positive
Solana	Very Positive

ClearPoint Neuro has a beta of 1.31, meaning that its stock price is 31% more volatile than the broader market. Comparatively, Solana has a beta of 1.06, meaning that its stock price is 6% more volatile than the broader market.

ClearPoint Neuro currently has a consensus price target of $18.00, indicating a potential upside of 33.93%. Solana has a consensus price target of $3.50, indicating a potential upside of 127.27%. Given Solana's stronger consensus rating and higher possible upside, analysts clearly believe Solana is more favorable than ClearPoint Neuro.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ClearPoint Neuro	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
Solana	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50

Summary

Solana beats ClearPoint Neuro on 8 of the 15 factors compared between the two stocks.

How does Solana compare to Delcath Systems?

Delcath Systems (NASDAQ:DCTH) and Solana (NASDAQ:HSDT) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, analyst recommendations, dividends, media sentiment, institutional ownership, earnings, risk and valuation.

Delcath Systems has higher revenue and earnings than Solana. Solana is trading at a lower price-to-earnings ratio than Delcath Systems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Delcath Systems	$85.23M	4.75	$2.70M	$0.01	1,172.00
Solana	$6.02M	14.94	-$40.89M	-$109.67	N/A

Delcath Systems presently has a consensus price target of $22.50, indicating a potential upside of 91.98%. Solana has a consensus price target of $3.50, indicating a potential upside of 127.27%. Given Solana's stronger consensus rating and higher possible upside, analysts clearly believe Solana is more favorable than Delcath Systems.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Delcath Systems	2 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.43
Solana	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50

Delcath Systems has a net margin of 0.62% compared to Solana's net margin of -1,427.15%. Delcath Systems' return on equity of 0.51% beat Solana's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Delcath Systems	0.62%	0.51%	0.46%
Solana	-1,427.15%	-67.57%	-24.09%

61.1% of Delcath Systems shares are held by institutional investors. Comparatively, 18.6% of Solana shares are held by institutional investors. 19.4% of Delcath Systems shares are held by insiders. Comparatively, 14.4% of Solana shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

In the previous week, Delcath Systems and Delcath Systems both had 1 articles in the media. Delcath Systems' average media sentiment score of 1.89 beat Solana's score of 1.87 indicating that Delcath Systems is being referred to more favorably in the media.

Company	Overall Sentiment
Delcath Systems	Very Positive
Solana	Very Positive

Delcath Systems has a beta of 0.54, meaning that its share price is 46% less volatile than the broader market. Comparatively, Solana has a beta of 1.06, meaning that its share price is 6% more volatile than the broader market.

Summary

Delcath Systems beats Solana on 11 of the 16 factors compared between the two stocks.

How does Solana compare to Conexeu Sciences?

Conexeu Sciences (NASDAQ:CNXU) and Solana (NASDAQ:HSDT) are both small-cap medical equipment companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, earnings, risk, media sentiment, analyst recommendations and valuation.

Conexeu Sciences has higher earnings, but lower revenue than Solana.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Conexeu Sciences	N/A	N/A	N/A	N/A	N/A
Solana	$6.02M	14.94	-$40.89M	-$109.67	N/A

18.6% of Solana shares are held by institutional investors. 14.4% of Solana shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Conexeu Sciences has a net margin of 0.00% compared to Solana's net margin of -1,427.15%. Conexeu Sciences' return on equity of 0.00% beat Solana's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Conexeu Sciences	N/A	N/A	N/A
Solana	-1,427.15%	-67.57%	-24.09%

Solana has a consensus target price of $3.50, suggesting a potential upside of 127.27%. Given Solana's stronger consensus rating and higher possible upside, analysts clearly believe Solana is more favorable than Conexeu Sciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Conexeu Sciences	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Solana	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50

In the previous week, Conexeu Sciences had 2 more articles in the media than Solana. MarketBeat recorded 3 mentions for Conexeu Sciences and 1 mentions for Solana. Solana's average media sentiment score of 1.87 beat Conexeu Sciences' score of 0.44 indicating that Solana is being referred to more favorably in the news media.

Company	Overall Sentiment
Conexeu Sciences	Neutral
Solana	Very Positive

Summary

Solana beats Conexeu Sciences on 8 of the 12 factors compared between the two stocks.

How does Solana compare to CapsoVision?

Solana (NASDAQ:HSDT) and CapsoVision (NASDAQ:CV) are both small-cap medical equipment companies, but which is the better investment? We will compare the two businesses based on the strength of their institutional ownership, media sentiment, dividends, valuation, risk, profitability, earnings and analyst recommendations.

CapsoVision has higher revenue and earnings than Solana. CapsoVision is trading at a lower price-to-earnings ratio than Solana, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Solana	$6.02M	14.94	-$40.89M	-$109.67	N/A
CapsoVision	$13.55M	26.51	-$25.32M	-$2.34	N/A

Solana presently has a consensus price target of $3.50, suggesting a potential upside of 127.27%. CapsoVision has a consensus price target of $8.50, suggesting a potential upside of 18.22%. Given Solana's higher probable upside, equities research analysts plainly believe Solana is more favorable than CapsoVision.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Solana	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50
CapsoVision	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50

18.6% of Solana shares are owned by institutional investors. 14.4% of Solana shares are owned by company insiders. Comparatively, 2.3% of CapsoVision shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

CapsoVision has a net margin of -198.87% compared to Solana's net margin of -1,427.15%. CapsoVision's return on equity of 0.00% beat Solana's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Solana	-1,427.15%	-67.57%	-24.09%
CapsoVision	-198.87%	N/A	-136.03%

In the previous week, CapsoVision had 1 more articles in the media than Solana. MarketBeat recorded 2 mentions for CapsoVision and 1 mentions for Solana. Solana's average media sentiment score of 1.87 beat CapsoVision's score of 1.32 indicating that Solana is being referred to more favorably in the media.

Company	Overall Sentiment
Solana	Very Positive
CapsoVision	Positive

Summary

CapsoVision beats Solana on 7 of the 13 factors compared between the two stocks.

How does Solana compare to Carlsmed?

Carlsmed (NASDAQ:CARL) and Solana (NASDAQ:HSDT) are both small-cap medical equipment companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, earnings, analyst recommendations, institutional ownership, risk, media sentiment, profitability and valuation.

18.6% of Solana shares are owned by institutional investors. 14.4% of Solana shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Carlsmed has a net margin of -57.76% compared to Solana's net margin of -1,427.15%. Carlsmed's return on equity of -60.74% beat Solana's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Carlsmed	-57.76%	-60.74%	-29.84%
Solana	-1,427.15%	-67.57%	-24.09%

In the previous week, Carlsmed had 1 more articles in the media than Solana. MarketBeat recorded 2 mentions for Carlsmed and 1 mentions for Solana. Solana's average media sentiment score of 1.87 beat Carlsmed's score of 0.43 indicating that Solana is being referred to more favorably in the news media.

Company	Overall Sentiment
Carlsmed	Neutral
Solana	Very Positive

Carlsmed has higher revenue and earnings than Solana. Carlsmed is trading at a lower price-to-earnings ratio than Solana, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Carlsmed	$50.51M	6.15	-$29.63M	-$2.51	N/A
Solana	$6.02M	14.94	-$40.89M	-$109.67	N/A

Carlsmed currently has a consensus price target of $19.33, indicating a potential upside of 69.29%. Solana has a consensus price target of $3.50, indicating a potential upside of 127.27%. Given Solana's stronger consensus rating and higher probable upside, analysts clearly believe Solana is more favorable than Carlsmed.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Carlsmed	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Solana	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50

Summary

Solana beats Carlsmed on 9 of the 16 factors compared between the two stocks.

Get Solana News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HSDT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

HSDT vs. The Competition

Export

Metric	Solana	MED INSTRUMENTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$88.16M	$7.21B	$6.75B	$12.02B
Dividend Yield	N/A	1.21%	2.66%	5.61%
P/E Ratio	-0.01	47.89	24.04	24.43
Price / Sales	14.94	71.27	510.75	109.73
Price / Cash	N/A	25.17	44.01	55.64
Price / Book	0.22	6.89	10.66	6.79
Net Income	-$40.89M	$159.22M	$3.56B	$337.66M
7 Day Performance	21.26%	-1.36%	0.05%	2.08%
1 Month Performance	-26.67%	3.84%	0.37%	3.16%
1 Year Performance	-94.87%	-0.34%	22.73%	27.78%

Solana Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
HSDT Solana	3.6107 of 5 stars	$1.54 +2.0%	$3.50 +127.3%	-97.3%	$88.16M	$6.02M	N/A	30	Positive News
CLPT ClearPoint Neuro	2.8388 of 5 stars	$12.36 -2.2%	$18.00 +45.6%	+7.7%	$379.07M	$40.61M	N/A	110	Analyst Forecast Gap Up
DCTH Delcath Systems	3.1574 of 5 stars	$10.52 -0.8%	$22.50 +114.0%	-26.3%	$365.93M	$90.44M	1,049.90	60	Positive News Gap Up
CNXU Conexeu Sciences	N/A	$16.23 +14.9%	N/A	N/A	$356.81M	N/A	N/A	4	Short Interest Increase High Trading Volume
CV CapsoVision	1.5948 of 5 stars	$6.89 -0.2%	$8.50 +23.4%	N/A	$338.76M	$13.56M	N/A	90	News Coverage

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:HSDT) was last updated on 6/12/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Solana (HSDT) Competitors

HSDT vs. CLPT, DCTH, CNXU, CV, and CARL

How does Solana compare to ClearPoint Neuro?

Summary

How does Solana compare to Delcath Systems?

Summary

How does Solana compare to Conexeu Sciences?

Summary

How does Solana compare to CapsoVision?

Summary

How does Solana compare to Carlsmed?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HSDT vs. The Competition

Solana Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Solana (HSDT) Competitors

HSDT vs. CLPT, DCTH, CNXU, CV, and CARL

How does Solana compare to ClearPoint Neuro?

Which has higher valuation & earnings, CLPT or HSDT?

Do institutionals & insiders believe in CLPT or HSDT?

Is CLPT or HSDT more profitable?

Does the media favor CLPT or HSDT?

Which has more risk & volatility, CLPT or HSDT?

Do analysts prefer CLPT or HSDT?

Summary

How does Solana compare to Delcath Systems?

Which has preferable earnings and valuation, DCTH or HSDT?

Do analysts rate DCTH or HSDT?

Is DCTH or HSDT more profitable?

Do insiders & institutionals believe in DCTH or HSDT?

Does the media favor DCTH or HSDT?

Which has more risk and volatility, DCTH or HSDT?

Summary

How does Solana compare to Conexeu Sciences?

Which has stronger valuation and earnings, CNXU or HSDT?

Do institutionals & insiders have more ownership in CNXU or HSDT?

Is CNXU or HSDT more profitable?

Do analysts recommend CNXU or HSDT?

Does the media favor CNXU or HSDT?

Summary

How does Solana compare to CapsoVision?

Which has higher valuation and earnings, HSDT or CV?

Do analysts rate HSDT or CV?

Do insiders & institutionals hold more shares of HSDT or CV?

Is HSDT or CV more profitable?

Does the media favor HSDT or CV?

Summary

How does Solana compare to Carlsmed?

Do insiders and institutionals have more ownership in CARL or HSDT?

Is CARL or HSDT more profitable?

Does the media refer more to CARL or HSDT?

Which has stronger valuation & earnings, CARL or HSDT?

Do analysts prefer CARL or HSDT?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HSDT vs. The Competition

Solana Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools